| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bio-Techne Corporation (NASDAQ: TECH)
TECH Technical Analysis
5
| As on 9th Jun 2023 TECH SHARE Price closed @ 78.43 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 370.82 & Strong Sell for SHORT-TERM with Stoploss of 421.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TECHSHARE Price
| Open | 79.20 | Change | Price | % |
| High | 79.40 | 1 Day | -0.86 | -1.08 |
| Low | 77.89 | 1 Week | -3.36 | -4.11 |
| Close | 78.43 | 1 Month | 0.73 | 0.94 |
| Volume | 613100 | 1 Year | -401.21 | -83.65 |
| 52 Week High 517.34 | 52 Week Low 71.62 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TECH Daily Charts |
TECH Intraday Charts |
Whats New @ Bazaartrend |
TECH Free Analysis |
|
|
TECH Important Levels Intraday
| RESISTANCE | 81.34 |
| RESISTANCE | 80.41 |
| RESISTANCE | 79.83 |
| RESISTANCE | 79.25 |
| SUPPORT | 77.61 |
| SUPPORT | 77.03 |
| SUPPORT | 76.45 |
| SUPPORT | 75.52 |
TECH Forecast April 2024
| 4th UP Forecast | 252.01 |
| 3rd UP Forecast | 196.34 |
| 2nd UP Forecast | 161.93 |
| 1st UP Forecast | 127.52 |
| 1st DOWN Forecast | 29.34 |
| 2nd DOWN Forecast | -5.07 |
| 3rd DOWN Forecast | -39.48 |
| 4th DOWN Forecast | -95.15 |
TECH Weekly Forecast
| 4th UP Forecast | 192.26 |
| 3rd UP Forecast | 155.75 |
| 2nd UP Forecast | 133.19 |
| 1st UP Forecast | 110.62 |
| 1st DOWN Forecast | 46.24 |
| 2nd DOWN Forecast | 23.67 |
| 3rd DOWN Forecast | 1.11 |
| 4th DOWN Forecast | -35.40 |
TECH Forecast2024
| 4th UP Forecast | 951.65 |
| 3rd UP Forecast | 671.6 |
| 2nd UP Forecast | 498.5 |
| 1st UP Forecast | 325.4 |
| 1st DOWN Forecast | -168.54 |
| 2nd DOWN Forecast | -341.64 |
| 3rd DOWN Forecast | -514.74 |
| 4th DOWN Forecast | -794.79 |
Bio-Techne Corporation ( NASDAQ USA Symbol : TECH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TECH Business Profile
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and nucleic acid analysis products for use in diagnostic or research applications, as well as instruments and process control products for hematology, blood chemistry, blood gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Novus Biologicals, Tocris Biosciences, ProteinSimple, Advanced Cell Diagnostics, and ExosomeDx brands. Bio-Techne Corporation has a clinical research collaboration with Carterra Inc. for the study of COVID-19 variants. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. Address: 614 McKinley Place N.E., Minneapolis, MN, United States, 55413
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service